The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for C Tallant


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
3
Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.EBI
Ludwig-Maximilians-Universit£T M£Nchen
8
Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.EBI
University of Athens
12
Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.EBI
University of Cambridge
23
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.EBI
Boehringer Ingelheim Rcv
3
Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.EBI
Pfizer
5
New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition.EBI
University of Dundee
25
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.EBI
University of Oxford
22
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.EBI
Glaxosmithkline
1
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.EBI
University of Oxford
1
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.EBI
University of Oxford
1
Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.EBI
Cancer Research Uk Cancer Therapeutics Unit
1
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.EBI
University of Oxford
1
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.EBI
University of Oxford
8
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.EBI
St. Jude Children'S Research Hospital
16
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.EBI
University College London
1
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.EBI
Bayer
1
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.EBI
University College London
4
Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their useBDB
St George'S Hosptial Medical School
55
Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.BDB
Parke-Davis Pharmaceutical Research